Navigation Links
Abilify Has Made Strong Gains in Patient Share Across All Lines of Therapy Since Last Year's Analysis of Prescribing Trends in Schizophrenia
Date:7/23/2009

WALTHAM, Mass., July 23 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the patient share of Bristol-Myers Squibb/Otsuka's Abilify has grown in the first three lines of therapy since the 2008 analysis of prescribing trends in newly diagnosed schizophrenia patients. Abilify is second to risperidone (Janssen's Risperdal, generics) in first and second lines of therapy and leads other atypicals in the third line.

"Abilify's first-line patient share grew from 4.2 percent in our 2008 analysis to 14.6 percent in the current dataset. Pfizer's Geodon also grew substantially compared with our 2008 analysis whereas both Eli Lilly's Zyprexa and AstraZeneca's Seroquel lost first-line patient share," stated Nicole Westphal, Ph.D., analyst at Decision Resources. "These data suggest that Abilify and Geodon's better penetration of first-line therapy came at the expense of others in the class and we attribute Zyprexa's and Seroquel's declining use across early lines of therapy to concerns about their metabolic side effects."

The new Treatment Algorithms in Schizophrenia report also finds that surveyed psychiatrists will remain focused on an agent's metabolic or weight gain side effects when treating current and newly diagnosed patients. The majority of surveyed psychiatrists will switch patients from atypicals with unfavorable metabolic side-effect profiles to those with more favorable profiles or increasingly consider weight gain and metabolic side-effect profiles when choosing an antipsychotic in the first-line.

By combining patient-level claims data with physician survey data, this report can be used to build patient-flow models and analyze the assumptions driving these models.

Patient-flow analysis for Janssen's Invega shows that only three perce
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Otsuka to Pay More Than $4 Million to Resolve Off-Label Marketing Allegations Involving Abilify
2. ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old
3. FDA approves ABILIFY(R) (aripiprazole) as the first medication for add-on treatment of MDD
4. ABILIFY(R) (aripiprazole) Supplemental New Drug Application for the Treatment of Pediatric Patients with Bipolar I Disorder Accepted for Priority Review by the U.S. Food and Drug Administration
5. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia
6. US FDA approves ABILIFY for adolescent patients with schizophrenia
7. Quest Diagnostics Reports Strong Performance in Second Quarter 2009
8. Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009
9. Minority Business Accelerator 2.5+ Client Strong Tool Lands Multimillion Dollar Deal With GE Healthcare
10. TeamPraxis Finishes Strong First Year of National Sales
11. Abatement Technologies Sees Strong Demand as Hospitals Prepare for Stage 6 Flu Pandemic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... Healthcare leaders will gather at the ... Walt Disney World Swan and Dolphin in Orlando, Fla., ... care delivery and healthcare reform and implementation. , “Reform ... markets, with consolidation, efficiency and reduced payments ... Ebert, Amerinet president and CEO. “There is a real ...
(Date:5/19/2013)... New York (PRWEB) May 19, 2013 ... in a federal litigation now underway in U.S. District ... Case Management Order dated May 3rd, the Court has ... Nominee Pool to eight cases rather than four. The ... scheduled for Thursday, May 23rd. (In re: Actos Product ...
(Date:5/19/2013)... According to a new market ... (2013 – 2018): By Applications (Healthcare (Endoscopy, Radiology, ... CMOS, Contact IS, Infrared, X-Ray) And Geography" published ... was $8.00 billion in 2012 and is expected ... estimated CAGR of 3.84% from 2013 to 2018. ...
(Date:5/19/2013)... May 19, 2013 Fat Burning Furnace ... program that provides people with fat burning diet ... order this Fat Burning Furnace package, people will receive ... they can download quickly. The Fat Burning Furnace manual ... people build lean muscle mass. In addition, this book ...
(Date:5/19/2013)... Dr. Keith Chertok now provides gum disease ... gums and increase the chance of a healthier smile. ... Procedure (LANAP) not only removes diseased gum tissue in patients, ... bone for dental implants. , LANAP uses a ... can also help stimulate the healthy tissue as well as ...
Breaking Medicine News(10 mins):Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2
... ... ... Golding is an avid cyclist and a man with a dream. His dream was ... programmer, it seemed Mr. Golding,s dream would never stand a chance competing with a multitude ...
... What,s the most effective way to convince young women to ... their risk of melanoma, the deadliest form of skin cancer, ... wrinkled skin. "They,re not worried about skin cancer, ... said June Robinson, a professor of dermatology at Northwestern University ...
... and inner-ear disorders, and Johns Hopkins University,s provost and ... the Prosper Mnire Society,s 2010 gold medal. The ... basis of Mnire,s disease, named for the French scientist ... "constant ringing noise in the head," or so-called tinnitus, ...
... difference, but others call this risky , MONDAY, May 17 ... not spread beyond the gland doesn,t make much difference in ... , "One thing that really surprised me was how good ... report on the study, published in the May issue of ...
... drugs in euthanasia and in cases without explicit ... according to a study in CMAJ ... . Euthanasia is legal in Belgium if ... care, one of which is that they discuss ...
... ... Records and Health Information Exchange , ... McHenry County, IL (Vocus) May 17, 2010 -- Centegra ... a health information technology sharing program that creates the region’s first-ever Health Information Exchange ...
Cached Medicine News:Health News:Former Microsoft Employee Combines Passion For Technology With American Made Chris King Bicycle Parts 2Health News:Former Microsoft Employee Combines Passion For Technology With American Made Chris King Bicycle Parts 3Health News:Wrinkles are scarier than skin cancer for young tanners 2Health News:Wrinkles are scarier than skin cancer for young tanners 3Health News:Johns Hopkins provost honored with international award 2Health News:Experts Divided on Whether to Treat Thyroid Cancer 2Health News:Experts Divided on Whether to Treat Thyroid Cancer 3Health News:The role of nurses in physician-assisted dying 2Health News:Centegra Health System Launches New Physician Network 2Health News:Centegra Health System Launches New Physician Network 3
(Date:5/18/2013)... Although colonoscopy exams prevent many colon cancer ... method for detecting colorectal cancers 2 , the procedure ... . EndoChoice ® Inc. today unveiled research that ... accuracy of this procedure and greatly reduces the number ... these clinical trial results and featuring the Fuse system ...
(Date:5/17/2013)... , May 17, 2013  Lakeland Industries, Inc. ... of protective clothing for industry, healthcare and to first ... release its financial results for the fiscal 2013 fourth ... May 21, 2013 at stock market close and will ... 4:30 p.m. eastern. (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ...
(Date:5/17/2013)... -- Sony Biotechnology Inc. ("Sony") today announced the launch of the ... chip.  Sony will also be exhibiting its newly rebranded reagent ... the EC800 flow cytometer, and new SP6800 Spectral Analyzer will ... be held at the San Diego ... from May 20 - 22.  The 8-well ...
Breaking Medicine Technology:New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Sony Delivers New Technology for Science to CYTO 2013 2
... , NEW YORK ... Kantar Health , a leading healthcare-focused consultancy and ... in tracking and evaluating pharmaceutical promotion on the prescribing behavior ... and Regimens, a timely, robust tool to assess oncology drug ...
... , PRINCETON, N.J. , Feb. 2 ... the Company), a late-stage biotechnology company, announced today the publication ... of Vaccine, which describes preclinical formulations of RiVax™, ... authored by the Company,s collaborators at the University of ...
Cached Medicine Technology:Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions 2Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions 3Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions 4Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 2Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 3Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 4Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 5Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 6Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 7
... aspirator is intended for destruction and removal ... operative interventions in the field of a ... In an operational zone in a consequence ... with liquid environment interaction arises cavitational processes. ...
... Dissectron ultrasonic aspirator, portable ... surgical aspirator for the ... tissue available only outside ... in a very compact ...
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 7.5 mm....
Medicine Products: